Skip to content Skip to menu

New Government investment a boost for clinical trial recruitment

Friday, 30 March 2012

Media Release

The Government’s investment in the Australian New Zealand Clinical Trial Registry will make it easier for patients to identify the clinical trials being conducted Australia, Medicines Australia chief executive Dr Brendan Shaw said today.

The investment will also make it easier for researchers to recruit patients into trials.

Dr Shaw said: “Improving patient recruitment is one area where we can do more, so this announcement is good news.

“Addressing the challenges in patient recruitment is one way to help reverse the dramatic decline we have seen in the number of clinical trials being conducted in Australia.

“Between 2007 and 2010 Australia suffered a 34 per cent decline in the number of new trials.

“Australia needs to take urgent action to rectify this situation. That action includes finalising the implementation of the recommendations of the Government’s Clinical Trials Action Group.

“Yesterday’s announcement was a positive step in the right direction and is therefore welcome.

“Patients who participate in clinical trials get early, and often free, access to new treatments which aren’t widely available to the community at large.


Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293


As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at